Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Hyperion Therapeutics 

2000 Sierra Point Parkway
Suite 400
San Francisco  California  94005  U.S.A.
Phone: 1-650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


 Company News
Hyperion Therapeutics (HPTX) To Present At 27th Annual ROTH Conference 3/6/2015 8:03:03 AM
Hyperion Therapeutics (HPTX) Observes Rare Disease Day 2015 2/27/2015 7:57:58 AM
Hyperion Therapeutics (HPTX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015 7:30:24 AM
Hyperion Therapeutics (HPTX) To Present At The Cowen and Company 35th Annual Health Care Conference 2/26/2015 8:20:54 AM
Hyperion Therapeutics (HPTX) To Report Fourth Quarter And Full Year 2014 Financial Results After Market On February 26, 2015 2/20/2015 7:30:39 AM
Hyperion Therapeutics (HPTX) Enters Into Completion Of Phase III Clinical Trial, Option And Mutual Release Agreement With Clal Biotechnology Industries And Yeda Research and Development Company Ltd. 2/17/2015 7:22:49 AM
Hyperion Therapeutics (HPTX) Initiates Clinical Study To Further Evaluate Ravicti In Pediatric Subjects Under Two Years Of Age With Urea Cycle Disorders 2/10/2015 7:39:40 AM
Hyperion Therapeutics (HPTX) To Present At The 2015 Leerink Global Healthcare Conference 2/5/2015 10:32:19 AM
Hyperion Therapeutics (HPTX) Announces Data Published In Genetics In Medicine Showing Blood Ammonia And Glutamine As Predictors Of Hyperammonemic Crises In Patients With Urea Cycle Disorders 1/12/2015 7:36:16 AM
Hyperion Therapeutics (HPTX) Added To Nasdaq Biotechnology Index (NBI) 12/19/2014 7:43:06 AM